dc.contributor.author | McClinton, Sam | |
dc.contributor.author | Starr, Kathryn | |
dc.contributor.author | Thomas, Ruth | |
dc.contributor.author | MacLennan, Graeme Stewart | |
dc.contributor.author | McPherson, Gladys | |
dc.contributor.author | McDonald, Alison | |
dc.contributor.author | Lam, Thomas | |
dc.contributor.author | N'Dow, James | |
dc.contributor.author | Kilonzo, Mary | |
dc.contributor.author | Pickard, Robert | |
dc.contributor.author | Anson, Ken | |
dc.contributor.author | Burr, Jennifer | |
dc.contributor.author | SUSPEND Study Group | |
dc.date.accessioned | 2014-07-23T15:16:00Z | |
dc.date.available | 2014-07-23T15:16:00Z | |
dc.date.issued | 2014-06-20 | |
dc.identifier.citation | McClinton , S , Starr , K , Thomas , R , MacLennan , G S , McPherson , G , McDonald , A , Lam , T , N'Dow , J , Kilonzo , M , Pickard , R , Anson , K , Burr , J & SUSPEND Study Group 2014 , ' Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin) : study protocol for a randomized controlled trial ' , Trials , vol. 15 , no. 1 , 238 . https://doi.org/10.1186/1745-6215-15-238 | en |
dc.identifier.issn | 1745-6215 | |
dc.identifier.other | PURE: 38636304 | |
dc.identifier.other | PURE UUID: 69880b7f-7971-4c4f-b86c-cc64b6ba426b | |
dc.identifier.other | PubMed: 24947817 | |
dc.identifier.other | PubMed: 24947817 | |
dc.identifier.other | Scopus: 84902707147 | |
dc.identifier.other | ORCID: /0000-0002-1039-5646/work/98038497 | |
dc.identifier.uri | http://hdl.handle.net/2164/3341 | |
dc.language.iso | eng | |
dc.relation.ispartof | Trials | en |
dc.rights | http://www.biomedcentral.com/about/license | en |
dc.subject | medical expulsive therapy | en |
dc.subject | nifedipine | en |
dc.subject | tamsulosin | en |
dc.subject | ureteric stone | en |
dc.subject | RM Therapeutics. Pharmacology | en |
dc.subject.lcc | RM | en |
dc.title | Use of drug therapy in the management of symptomatic ureteric stones in hospitalized adults (SUSPEND), a multicentre, placebo-controlled, randomized trial of a calcium-channel blocker (nifedipine) and an α-blocker (tamsulosin) : study protocol for a randomized controlled trial | en |
dc.type | Journal article | en |
dc.contributor.institution | University of Aberdeen.Applied Medicine | en |
dc.contributor.institution | University of Aberdeen.Health Services Research Unit | en |
dc.contributor.institution | University of Aberdeen.Academic Urology Unit | en |
dc.contributor.institution | University of Aberdeen.Other Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Institute of Applied Health Sciences | en |
dc.contributor.institution | University of Aberdeen.Health Economics Research Unit | en |
dc.description.status | Peer reviewed | en |
dc.description.version | Publisher PDF | en |
dc.identifier.doi | https://doi.org/10.1186/1745-6215-15-238 | |
dc.identifier.url | http://www.trialsjournal.com/content/15/1/238 | en |
dc.identifier.vol | 15 | en |
dc.identifier.iss | 1 | en |